Skip to content

Noninvasive Hemoglobin Testing, Prospective Blood Donors

Noninvasive Hemoglobin Testing in Prospective Blood Donors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04450381
Enrollment
131
Registered
2020-06-29
Start date
2020-06-23
Completion date
2020-07-07
Last updated
2021-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia, Healthy

Brief summary

The objective of this clinical investigation is to evaluate the pulse oximeter devices for screening prospective blood donors. The purpose study is to report on the accuracy of noninvasive hemoglobin (SpHb) as compared to hemoglobin measurements obtained from a laboratory hematology analyzer in a blood donation setting.

Interventions

Noninvasive pulse oximeter that measures hemoglobin

Sponsors

Masimo Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* At least 18 years of age * Weight at least 110 pounds * Subjects with the intention of being screened for eligibility to donate blood * The subject has given written informed consent to participate in the study

Exclusion criteria

* Subjects with skin abnormalities at the planned application sites that may interfere with sensor application, per directions-for-use (DFU) or trans-illumination of the site, such as burns, scar tissue, infections, abnormalities, etc. * Subjects unwilling and/or unable to remove nail polish or acrylic nails * Subjects with blood cancers such as leukemia * Subjects with hemoglobin disorders such as sickle-cell anemia and thalassemia * Subjects with known history of infectious diseases such as HIV/AIDS, syphilis, hepatitis, etc. * Subjects with self-disclosed/known pregnancy at the time of enrollment * Subjects deemed not suitable for the study at the discretion of the investigator * Excessive motion includes postural changes, making hand gestures, involuntary muscular movements, etc.

Design outcomes

Primary

MeasureTime frameDescription
Rad-67 SensitivityUp to one hour per subjectSensitivity of the the Rad-67 will be determined for its use in a blood donation center
Rad-67 SpecificityUp to one hour per subjectSpecificity of the the Rad-67 will be determined for its use in a blood donation center

Countries

United States

Participant flow

Participants by arm

ArmCount
Test Subjects
All subjects are enrolled and receive Rad-67 Pulse oximeter & DCI Mini sensor for measurement of hemoglobin. Rad-67 Pulse oximeter & DCI Mini sensor: Noninvasive pulse oximeter that measures hemoglobin
125
Total125

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyProtocol Violation4
Overall StudyWrong device setting2

Baseline characteristics

CharacteristicTest Subjects
Age, Categorical
<=18 years
1 Participants
Age, Categorical
>=65 years
18 Participants
Age, Categorical
Between 18 and 65 years
106 Participants
Race/Ethnicity, Customized
Race
American Indian or Alaska Native
1 Participants
Race/Ethnicity, Customized
Race
Asian
16 Participants
Race/Ethnicity, Customized
Race
Black or African American
2 Participants
Race/Ethnicity, Customized
Race
More Than One Race
6 Participants
Race/Ethnicity, Customized
Race
Native Hawaiian or Other Pacific Islander
2 Participants
Race/Ethnicity, Customized
Race
Other: American
1 Participants
Race/Ethnicity, Customized
Race
Other: Assyrian
1 Participants
Race/Ethnicity, Customized
Race
Other: Mexican
16 Participants
Race/Ethnicity, Customized
Race
Other: Native American
1 Participants
Race/Ethnicity, Customized
Race
Unknown or Not Reported
3 Participants
Race/Ethnicity, Customized
Race
White
76 Participants
Region of Enrollment
United States
125 participants
Sex: Female, Male
Female
76 Participants
Sex: Female, Male
Male
49 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 131
other
Total, other adverse events
0 / 131
serious
Total, serious adverse events
0 / 131

Outcome results

Primary

Rad-67 Sensitivity

Sensitivity of the the Rad-67 will be determined for its use in a blood donation center

Time frame: Up to one hour per subject

Population: 2 subjects were excluded from analysis due to wrong device setting

ArmMeasureValue (NUMBER)
Test SubjectsRad-67 Sensitivity44 percentage of sensitivity
Primary

Rad-67 Specificity

Specificity of the the Rad-67 will be determined for its use in a blood donation center

Time frame: Up to one hour per subject

Population: 2 subjects were excluded from analysis due to wrong device setting

ArmMeasureValue (NUMBER)
Test SubjectsRad-67 Specificity86.73 percentage of specificity

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026